Analysis of the adverse events of Aristada:A real-world study based on FAERS database

被引：2
|
作者：
Ou, Mengmeng [1 ]
Zhou, Qin [1 ]
Zhu, Haohao [1 ]
Du, Zhiqiang [1 ]
Shen, Yuan [1 ]
Luan, Peipei [1 ]
Jiang, Ying [1 ]
机构：
[1] Jiangnan Univ, Wuxi Cent Rehabil Hosp, Mental Hlth Ctr, Wuxi 214151, Jiangsu, Peoples R China
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2024年 / 94卷
基金：
中国国家自然科学基金;
关键词：
Aristada; FDA adverse event reporting system; Real -world data analysis; Adverse events; Adverse drug reactions;
D O I：
10.1016/j.ajp.2024.103968
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Safety assessment of Yasmin: Real-world adverse event analysis using the FAERS database
    Xu, Wenting
    Zhu, Lili
    Wang, Jiahui
    Shi, Lingli
    Tang, Xiuqin
    Chen, Qingli
    Wang, Lihong
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 301 : 12 - 18
  • [22] Safety assessment of Brexpiprazole: Real-world adverse event analysis from the FAERS database
    Jiang, Ying
    Zhou, Lingyun
    Shen, Yuan
    Zhou, Qin
    Ji, Yingying
    Zhu, Haohao
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 346 : 223 - 229
  • [23] Safety assessment of apremilast: real-world adverse event analysis from the FAERS database
    Landong Ren
    Kaidi Zhao
    Bingqing Wang
    Shengxiang Xiao
    Jiashu Liu
    Chen Tu
    Archives of Dermatological Research, 317 (1)
  • [24] Neratinib safety evaluation: real-world adverse event analysis from the FAERS database
    Fan, Yunhe
    Wu, Teng
    Xu, Pengyang
    Yang, Chuanli
    An, Jie
    Zhang, Haijia
    Abbas, Mureed
    Dong, Xiushan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [25] Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database
    Chen, Shihao
    Fang, Wenqiang
    Zhao, Linqian
    Xu, Huiqin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [26] Renal injury in NSAIDs: a real-world analysis based on the FAERS database
    Haojie Xu
    Jiaming Cao
    Hongyi Zhang
    Fenglong Fei
    Dongming Tang
    Donghua Liu
    Dongbin Luo
    International Urology and Nephrology, 2025, 57 (3) : 957 - 963
  • [27] Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database
    Wu, Junlin
    Wu, Hanbiao
    Chen, Lili
    Liang, Haiping
    Huang, Guoning
    Yang, Sensen
    Chen, Bishan
    Noguchi, Yoshihiro
    Shen, Yonggang
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (07) : 905 - 916
  • [28] Haemorrhage-related adverse events profles of lenvatinib and pembrolizumab alone or in combination: a real-world pharmacovigilance study based on FAERS database
    Shiqiao Wang
    Guizhi Ren
    Heng Pan
    Jiayi Chen
    Jiayu Huang
    Qinghua Mei
    Zhongze Li
    Guosheng Zou
    BMC Pharmacology and Toxicology, 26 (1)
  • [29] Hematological adverse events associated with anti-MRSA agents: a real-world analysis based on FAERS
    Yu, Xiuheng
    Zhou, Xiaodan
    Li, Min
    Zhao, Yu
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [30] Assessment of adverse events of the novel cardiovascular drug vericiguat: a real-world pharmacovigilance study based on FAERS
    Rao, Jin
    Chen, Xiangyu
    Liu, Yudi
    Wang, Xuefu
    Cheng, Pengchao
    Wang, Zhinong
    EXPERT OPINION ON DRUG SAFETY, 2024,
12345